The global nuclear medicine equipment market size is expected to reach a value of USD 8.47 billion by 2030 and is projected to grow at a CAGR of 3.1% from 2024 to 2030. Nuclear medicine involves the utilization of radiation to diagnose diseases or treat them. It also involves determining whether specific organs are functioning normally. Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice.
With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year. It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.
This product will be delivered within 1-3 business days.
With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year. It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.
Nuclear Medicine Equipment Market Report Highlights
- The North American market is expected to register lucrative growth owing to increasing preference for SPECT and PET scans for diagnosis of chronic diseases
- Growing awareness and government initiatives pertaining to usage of radiopharmaceuticals in the North American region is expected to boost usage rates. For instance, in December 2016, the FDA issued new guidelines to enforce FDA’s proposed policies regarding compounding and repackaging of radiopharmaceuticals for human use in the U.S.
- Oncology accounted for the largest market share in application segment in the year 2023 owing to the increasing incidence and prevalence of cancer worldwid
- Asia Pacific market is expected to witness significant growth owing to Japan, China, and India where use of nuclear medicine is increasing at a fast pace. In addition, the usage of radioimmunotherapy-based targeted cancer treatment to counter incidence of cancer and cardiovascular diseases is aiding in the growth of the market
- The key players are focused on expansion & penetration opportunities in developing and emerging economies to achieve sustainable growth in the market
The leading players in the Nuclear Medicine Equipment market include:
- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- CANON MEDICAL SYSTEMS CORPORATION
- TTG IMAGING SOLUTIONS
- Mediso Ltd.
- CMR Naviscan
- Neusoft Corporation.
- Shenzhen Anke High-tech Co., Ltd.
- Bracco Imaging S.p.A.
- Biosensors International Group, Ltd.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Global Nuclear Medicine Equipment Market Variables, Trends, & Scope
Chapter 4. Global Nuclear Medicine Equipment Market: Type Estimates & Trend Analysis
Chapter 5. Global Nuclear Medicine Equipment Market: Application Estimates & Trend Analysis
Chapter 6. Globe Nuclear Medicine Equipment Market: End Use Estimates & Trend Analysis
Chapter 7. Globe Nuclear Medicine Equipment Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
The leading players in the Nuclear Medicine Equipment market include:- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- CANON MEDICAL SYSTEMS CORPORATION
- TTG IMAGING SOLUTIONS
- Mediso Ltd.
- CMR Naviscan
- Neusoft Corporation.
- Shenzhen Anke High-tech Co., Ltd.
- Bracco Imaging S.p.A.
- Biosensors International Group, Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.87 Billion |
| Forecasted Market Value ( USD | $ 8.47 Billion |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
